|
From high-throughput early screening to deciphering surprise results during pre-clinical and initial clinical studies, HemoGenix® is a trusted contract research partner during all stages of drug development.
Learn more about our best-in-class capabilities for lympho-hematotoxicity and other in vitro toxicity models by visiting our website. To evaluate whether we can assist you with your study and to receive a quotation, contact us directly at: (719) 264-6250 or screening@hemogenix.com.
HemoGenix® has partnered with Preferred Cell Systems™ to make the same testing platforms used for contract research services available for in-house use. To learn more about the full line of in vitro assay kits and cell culture media, visit the website below or contact PCS™ directly: (719) 264-6251 or info@preferred-cell-systems.com.
| 
